ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022: Tumor Mutational Burden as a Predictive Biomarker for Immune CPI vs. Chemo Benefit in 1L mUC

68 views
March 14, 2022
Comments 0
Login to view comments. Click here to Login